Cancer-Related Fatigue

Ann M. Berger, Amy Pickar Abernethy, Ashley Atkinson, +16

Journal of the National Comprehensive Cancer Network

Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131

Ingrid A. Mayer, Fengmin Zhao, Carlos L. Arteaga, +22

Journal of Clinical Oncology

NY‐ESO‐1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma

Seth M. Pollack, Achim A. Jungbluth, Benjamin Hoch, +9

Cancer

Phase I Study of Veliparib (ABT-888) Combined with Cisplatin and Vinorelbine in Advanced Triple-Negative Breast Cancer and/or <i>BRCA</i> Mutation–Associated Breast Cancer

Eve T. Rodler, Brenda F. Kurland, Melissa Griffin, +16

Clinical Cancer Research

Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial

Eve T. Rodler, Priyanka Sharma, William E. Barlow, +18

The Lancet Oncology

Breast OncologyMedicinePharmacologyPathologyBreast Cancer +4

A Contemporary Large Single-Institution Evaluation of Resected Retroperitoneal Sarcoma

Prashoban Bremjit, Robin L. Jones, Xiaoyu Chai, +6

Annals of Surgical Oncology

Resected Retroperitoneal SarcomaSurgical OncologyGastrointestinal OncologyMedicineSurgery +1

Phase I Trial of Preoperative Chemoradiation plus Sorafenib for High-Risk Extremity Soft Tissue Sarcomas with Dynamic Contrast-Enhanced MRI Correlates

Janelle Marie Meyer, Kelly S. Perlewitz, James B. Hayden, +15

Clinical Cancer Research

NYESO-1/LAGE-1s and PRAME Are Targets for Antigen Specific T Cells in Chondrosarcoma following Treatment with 5-Aza-2-Deoxycitabine

Seth M. Pollack, Yonqing Li, Megan J. Blaisdell, +9

PLoS ONE

Results of a phase II randomized trial of cisplatin +/- veliparib in metastatic triple-negative breast cancer (TNBC) and/or germline <i>BRCA</i>-associated breast cancer (SWOG S1416).

Priyanka Sharma, Eve T. Rodler, William E. Barlow, +17

Journal of Clinical Oncology

Tumor BiologyBrca1 MethylationBreast OncologyPhase IiMedicine +13

Clinical benefit of antiangiogenic therapy in advanced and metastatic chondrosarcoma

Robin L. Jones, Daniela Katz, Elizabeth T. Loggers, +3

Medical Oncology

Surgical OncologyMedicineCartilage DegenerationPathologyClinical Benefit +2